Emerging data suggest Retatrutide , a dual stimulator targeting both GLP-1 and GIP , may provide a notable step forward for body management . Early patient trials have shown substantial decreases https://getretatrutideaustralia.com/blog/retatrutide-weight-loss-revolution-2026